Gene therapy to modify killer T cells to specifically recognize and kill HIV-infected cells: Completed enrollment of 29 patients for Phase I testing. The Phase

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: Gene therapy to modify killer T cells to specifically recognize and kill HIV-infected cells Indication: AIDS Status: Completed enrollment of 29 p...